Volume 33, Issue 3
Research Article

Sample size calculation for comparing two negative binomial rates

Haiyuan Zhu

Corresponding Author

Forest Research Institute, Harborside Financial Center, Jersey City, NJ 07311, U.S.A.

Correspondence to: Haiyuan Zhu, Forest Research Institute, Harborside Financial Center, Plaza V, Jersey City, NJ 07311, U.S.A.

E‐mail:haiyuan.zhu@frx.com

Search for more papers by this author
Hassan Lakkis

Forest Research Institute, Harborside Financial Center, Jersey City, NJ 07311, U.S.A.

Search for more papers by this author
First published: 23 August 2013
Citations: 30

Abstract

Negative binomial model has been increasingly used to model the count data in recent clinical trials. It is frequently chosen over Poisson model in cases of overdispersed count data that are commonly seen in clinical trials. One of the challenges of applying negative binomial model in clinical trial design is the sample size estimation. In practice, simulation methods have been frequently used for sample size estimation. In this paper, an explicit formula is developed to calculate sample size based on the negative binomial model. Depending on different approaches to estimate the variance under null hypothesis, three variations of the sample size formula are proposed and discussed. Important characteristics of the formula include its accuracy and its ability to explicitly incorporate dispersion parameter and exposure time. The performance of the formula with each variation is assessed using simulations. Copyright © 2013 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 30

  • Choice of library size normalization and statistical methods for differential gene expression analysis in balanced two-group comparisons for RNA-seq studies, BMC Genomics, 10.1186/s12864-020-6502-7, 21, 1, (2020).
  • Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: study protocol for a randomized controlled trial, Trials, 10.1186/s13063-020-04467-z, 21, 1, (2020).
  • On the utility of RNA sample pooling to optimize cost and statistical power in RNA sequencing experiments, BMC Genomics, 10.1186/s12864-020-6721-y, 21, 1, (2020).
  • Sample Size Calculation for “Gold-Standard” Noninferiority Trials With Fixed Margins and Negative Binomial Endpoints, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1766551, (1-13), (2020).
  • An Improved Sample Size Calculation Method for Score Tests in Generalized Linear Models, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1756398, (1-10), (2020).
  • Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure, European Journal of Heart Failure, 10.1002/ejhf.1710, 21, 12, (1651-1658), (2019).
  • Academic library as learning space and as collection: A learning commons' effects on collections and related resources and services, The Journal of Academic Librarianship, 10.1016/j.acalib.2019.04.004, 45, 3, (305-314), (2019).
  • Sample size calculations for the differential expression analysis of RNA-seq data using a negative binomial regression model, Statistical Applications in Genetics and Molecular Biology, 10.1515/sagmb-2018-0021, 18, 1, (2019).
  • Are young female suicides increasing? A comparison of sex-specific rates and characteristics of youth suicides in Australia over 2004–2014, BMC Public Health, 10.1186/s12889-019-7742-9, 19, 1, (2019).
  • Sample size calculation for clinical trials with correlated count measurements based on the negative binomial distribution, Statistics in Medicine, 10.1002/sim.8378, 38, 28, (5413-5427), (2019).
  • Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements, Statistics in Biopharmaceutical Research, 10.1080/19466315.2019.1575277, (1-20), (2019).
  • RNASeqDesign: a framework for ribonucleic acid sequencing genomewide power calculation and study design issues, Journal of the Royal Statistical Society: Series C (Applied Statistics), 10.1111/rssc.12330, 68, 3, (683-704), (2018).
  • Sample size re‐estimation for clinical trials with longitudinal negative binomial counts including time trends, Statistics in Medicine, 10.1002/sim.8061, 38, 9, (1503-1528), (2018).
  • A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes, Pharmaceutical Statistics, 10.1002/pst.1913, 18, 2, (184-197), (2018).
  • Sample size calculations for comparing two groups of count data, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2018.1489409, 29, 1, (115-127), (2018).
  • A Re-examination of Japanese Sample Size Calculation for Multi-regional Clinical Trial Evaluating Survival Endpoint, Japanese Journal of Biometrics, 10.5691/jjb.38.79, 38, 2, (79-92), (2018).
  • Power and sample size calculation incorporating misspecifications of the variance function in comparative clinical trials with over‐dispersed count data, Biometrics, 10.1111/biom.12878, 74, 4, (1459-1467), (2018).
  • Cumulative References, Sample Sizes for Clinical, Laboratory and Epidemiology Studies, 10.1002/9781118874905, (363-380), (2018).
  • Rate Outcomes, Sample Sizes for Clinical, Laboratory and Epidemiology Studies, 10.1002/9781118874905, (83-98), (2018).
  • PrEP Chicago : A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men , Clinical Trials, 10.1177/1740774517730012, 15, 1, (44-52), (2017).
  • Sample size for comparing negative binomial rates in noninferiority and equivalence trials with unequal follow-up times, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1333998, 28, 3, (475-491), (2017).
  • Models of Protection Against Recidivism in Justice-Involved Adults With Mental Illnesses, Criminal Justice and Behavior, 10.1177/0093854817710966, 44, 7, (893-911), (2017).
  • Sample size determination for a three-arm equivalence trial of Poisson and negative binomial responses, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2016.1269787, 27, 2, (239-256), (2016).
  • Sample Size Calculation for Comparing Two Poisson or Negative Binomial Rates in Noninferiority or Equivalence Trials, Statistics in Biopharmaceutical Research, 10.1080/19466315.2016.1225594, 9, 1, (107-115), (2016).
  • Improving the Language Skills of Pre-kindergarten Students: Preliminary Impacts of the Let’s Know! Experimental Curriculum, Child & Youth Care Forum, 10.1007/s10566-015-9332-z, 45, 3, (367-392), (2015).
  • Sample size calculations for skewed distributions, BMC Medical Research Methodology, 10.1186/s12874-015-0023-0, 15, 1, (2015).
  • Confidence interval estimation for number of patient‐years needed to treat, Pharmaceutical Statistics, 10.1002/pst.1650, 13, 6, (403-409), (2014).
  • Authors' reply to comments on ‘Sample size calculation for comparing two negative binomial rates’, Statistics in Medicine, 10.1002/sim.6186, 33, 16, (2880-2880), (2014).
  • Comments on ‘Sample size calculation for comparing two negative binomial rates’, Statistics in Medicine, 10.1002/sim.6119, 33, 11, (1979-1979), (2014).
  • Incorporating pragmatic features into power analysis for cluster randomized trials with a count outcome, Statistics in Medicine, 10.1002/sim.8707, 0, 0, (undefined).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.